Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Leïla Bengrine-Lefevre"'
Autor:
Marylise Sterlé, Alicja Puszkiel, Chloé Burlot, Eva Pereira, Audrey Bellesoeur, Sixtine De Percin, Guillaume Beinse, Jean-David Fumet, Laure Favier, Julie Niogret, Benoit Blanchet, Bernard Royer, Leïla Bengrine-Lefevre, Antonin Schmitt
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 16 (2024)
Background: Olaparib is an inhibitor of the human poly-(ADP-ribose)-polymerase enzymes (PARP1/2) needed to repair single-strand DNA breaks. It is used in breast, ovarian, prostate and pancreatic cancer. Objectives: This work aimed to describe the pha
Externí odkaz:
https://doaj.org/article/17dc600b679a41a78f45ee1236fd3361
Autor:
Marine Dolat, Pauline Macaire, Françoise Goirand, Julie Vincent, Audrey Hennequin, Rémi Palmier, Leïla Bengrine-Lefevre, François Ghiringhelli, Bernard Royer, Antonin Schmitt
Publikováno v:
Pharmaceuticals, Vol 13, Iss 11, p 416 (2020)
In order to limit 5-fluorouracil (5-FU) toxicity, some health agencies recommend evaluating dihydropyrimidine dehydrogenase (DPD) deficiency before any 5-FU treatment introduction. In our study, we investigated relationships between 5-FU clearance an
Externí odkaz:
https://doaj.org/article/2727cb6f3dc8433c8d2343ce7077980a
Autor:
HELOÏSE BOURIEN, LEÏLA BENGRINE LEFEVRE, MARIE-ANGE MOURET-REYNIER, BERNARD ASSELAIN, BRIGITTE LUCAS, CELINE GAVOILLE, CORINA CORNILA, LAURENE GAVOILLE, EMELINE COLOMBA, ANNE PATSOURIS, MICHEL FABBRO, CAMILLE CHAKIBA, PHILIPPE TOUSSAINT, HELENE SIMON, DOMINIQUE BERTON, DELPHINE GARBAY, CLAIRE GARNIER TIXIDRE, DAVID COEFFIC, AURELIE MORVAN, OLIVIER COLLARD, THIBAULT DE LA MOTTE ROUGE
Publikováno v:
Anticancer Research. 43:653-662
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::66a2daed9e7f79cb3d13dbe15488c9ed
https://doi.org/10.21873/anticanres.16202
https://doi.org/10.21873/anticanres.16202
Autor:
Leïla Bengrine Lefevre, Anaïs Fouquier, Isabelle Ray-Coquard, Laure Favier, Florence Joly, Manuel Rodrigues, Baptiste Sauterey, Pierre Emmanuel Colombo, Anne Floquet, Eric Leblanc, Rene Sabatier, Emmanuel Barranger, Aude-Marie Savoye, Patricia Pautier, Thierry Petit, Jean-Marc Classe, Christophe Pomel, Aurelie Bertaut, Loîc Mourey, Lise Bosquet, Claire Falandry
Publikováno v:
Ovarian cancer.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::954ef44b453f2c31b41ed1f56e2edb8f
https://doi.org/10.1136/ijgc-2022-esgo.741
https://doi.org/10.1136/ijgc-2022-esgo.741
Autor:
Florence Joly, Michel Fabbro, Dominique Berton, Justine Lequesne, Amélie Anota, Alicja Puszkiel, Anne Floquet, Hélène Vegas, Hugues Bourgeois, Leïla Bengrine Lefevre, Benoît You, Fanny Pommeret, Alain Lortholary, Dominique Spaeth, Anne-Claire Hardy-Bessard, Cyril Abdeddaim, Marie-Christine Kaminsky-Forrett, Michel Tod, Jean-Emmanuel Kurtz, Francesco Del Piano, Jérôme Meunier, Nadia Raban, Jérome Alexandre, Marie-Ange Mouret-Reynier, Isabelle Ray-Coquard, Magali Provansal Gross, Pierre-Emmanuel Brachet
Publikováno v:
Gynecologic Oncology
Gynecologic Oncology, 2022, 166 (3), pp.389-396. ⟨10.1016/j.ygyno.2022.06.022⟩
Gynecologic Oncology, 2022, 166 (3), pp.389-396. ⟨10.1016/j.ygyno.2022.06.022⟩
Anti-angiogenic rechallenge with bevacizumab plus chemotherapy is effective in recurrent ovarian cancer (rOC); however, data are limited on tyrosine kinase inhibitors after progression on maintenance bevacizumab.In the randomized phase II TAPAZ trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::655dbf1d8d8bd14e892d16da08ad1540
https://pubmed.ncbi.nlm.nih.gov/35902297
https://pubmed.ncbi.nlm.nih.gov/35902297
Publikováno v:
Molecular and Clinical Oncology. 13:73-75
PARP inhibitors are considered as a treatment revolution in ovarian cancer management. Leptomeningeal metastasis is a rare event with poor prognosis. The present report presents an exceptional history of long term survival for a young patient treated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c02d572eed1faa6d90e2024108fa8416
https://doi.org/10.3892/mco.2020.2035
https://doi.org/10.3892/mco.2020.2035
Publikováno v:
Mol Clin Oncol
PARP inhibitors are considered as a treatment revolution in ovarian cancer management. Leptomeningeal metastasis is a rare event with poor prognosis. The present report presents an exceptional history of long term survival for a young patient treated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6cd46ac61960691bd5a9389c52487327
https://pubmed.ncbi.nlm.nih.gov/32454976
https://pubmed.ncbi.nlm.nih.gov/32454976
Autor:
Frédérique Rousseau, Florence Ranchon, Christophe Bardin, Naoual Bakrin, Vincent Lavoué, Leila Bengrine-Lefevre, Claire Falandry
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 15 (2023)
In recent years, major advances have been made toward the individualization of epithelial ovarian cancer care, leading to an overall improvement of patient outcomes. However, real-life data indicate that the oldest populations do not benefit from thi
Externí odkaz:
https://doaj.org/article/b7b6a5c2e1af418599171b1b3cb34f98
Autor:
Katia Mahiou, Laura Vincent, Karine Peignaux‐Casasnovas, Hélène Costaz, Marie‐Martine Padeano, Alix Amet, Sandrine Dabakuyo, Ariane Mamguem Kamga, Leila Bengrine‐Lefevre, Charles Coutant
Publikováno v:
Cancer Reports, Vol 6, Iss 5, Pp n/a-n/a (2023)
Abstract Background and Objectives There is no international consensus for management of early‐stage cervical cancer (ESCC). This study aimed to retrospectively investigate disease‐free survival (DFS) and overall survival (OS) in patients with ES
Externí odkaz:
https://doaj.org/article/56ee345674de41b2a6b7f1e234bda795
Autor:
Leïla Bengrine-Lefevre, Najat Mourra
Publikováno v:
Applied Immunohistochemistry & Molecular Morphology. 18:574-576
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5201d2d784119b9fae3becc228a13e2b
https://doi.org/10.1097/pai.0b013e3181e8dbe0
https://doi.org/10.1097/pai.0b013e3181e8dbe0